Robotic Surgery is on the cusp of being Affordable – Dr Sangita Reddy

Apollo Spectra in Delhi joins Apollo group’s robotic surgery’s triumphal march

New Delhi: The era of robotic surgery being affordable and accessible for all has dawned in India. Dr. Sangita Reddy, Joint Managing Director, Apollo Hospitals group pitch, underlined this while unveiling installation of robots in Apollo Spectra hospital in Delhi (pusa road). The event marked the installation of two surgical robots SSIManta and Meril CUVIS.. The presence of Abhinav Bindra Olympic gold medalist sport shooter on the occasion well underscored precision and accuracy being the attributes of robotic surgeries.

SSI Mantra is the only one ‘Made in India’ surgical robot among many imported ones being harnessed in hospitals in India. SSI Mantra being most affordable despite being best in class is giving MNC makers of surgical robot run for their money. Before dawn of SSI Mantra, the question of affordability and accessibility was a major hindrance in the way of best tool for surgery becoming most sought after choice. Apollo Spectra is the third Apollo hospital to embrace SSI Mantra. Apollo proton Cancer Centre, Chennai has achieved India’s first robotic telesurgery for colorectal cancer using SSIMantra. Apollo JBP Hospital , Jbalpur too has SSIMantra to boast of best surgical outcomes.

In Apollo Spectra Hospital’s multirobot ecosystem, SSI Mantra has a pride of place. Apollo group of hospitals, being pioneer in robotic surgery with over 25000 robotic surgeries so far, most probably the highest and best benchmark in Indian healthcare, is a badge of honour on SSIMantra and testament to the fact that SSIMantra is one of the best in class surgical robots.

Oplus_16908288

Apollo Spectra Hospital multi-robot surgical ecosystem is being supported by personalised 3D surgical planning. This move marks a milestone in minimally invasive care in the country. This multirobot surgical system enables Apollo Spectra to do both soft tissue and bone surgeries. One of the flagship additions is Meril CUVIS Joint Robotic System, considered among the most advanced platforms for the knee and hip replacement. Accompanying this, is,Robotic Soft Tissue Surgery powered by the SSI Mantra Surgical Robot, India’s advanced multi-specialty platform designed for general surgery, urology and gynaecology procedures. To compliment these formats, and provide holistic care Apollo Spectra has also introduced fully integrated 3D modeling surgery.

Speaking at the launch, Dr. Sangita Reddy, Joint Managing Director, Apollo Hospitals groupsaid, This integration under one roof ensures our patients receive the highest standard of safety and predictability across both major orthopedic and complex soft tissue procedures. This is a quantum leap from a single robotic solution that allows us to deliver our signature technology-backed, short-stay surgical model, ensuring that busy professionals and active senior citizens alike benefit from minimal invasiveness, lower complications, and a significantly faster recovery time.”

Indian former sport shooter, Padma Bhushan and a Businessman now Abhinav Bindra,said, “It is inspiring to see Apollo’s proactive approach to healthcare, consistently investing in future-ready medical technology to elevate standards of excellence. Robotics ensures a good level of accuracy and safety that patients truly deserve, making advanced surgical care more accessible. This initiative by Apollo Spectra represents the direction in which the surgical ecosystem of India must move, setting a standard that will rapidly become the expectation for all patients seeking high-quality, precise, and safer surgical outcomes across the country.”

With its multi robot offering, and modified planning tools, Apollo Spectra Hospital, is now positioned to become a key contributor to Delhi NCR landscape of precision surgery. The centre will also play a significant role in bringing world class, minimally invasive, and fast surgical recovery options to a wider population helping to shape the future of short stay surgical care in India.

Related Posts

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre